Cigna Corporation

(New York Stock Exchange)
Back to all articles
Bullish +65

1,964 Shares in Cigna Group $CI Bought by Ascentis Independent Advisors

AI-generated analysis

πŸ“ˆ Ascentis Independent Advisors purchased 1,964 shares of Cigna Group valued at approximately $524,000 in the first quarter.

🏦 Cary Street Partners increased its stake by 11.0% to own 363 shares worth $100,000 during the fourth quarter.

πŸ“Š Mizuho raised its price objective from $330.00 to $340.00 and maintained an outperform rating on Cigna Group.

πŸ’° Cigna reported Q1 EPS of $7.79, topping analyst estimates of $7.60 with revenue of $68.52 billion.

πŸ“‰ CEO David Cordani sold 201,878 shares for approximately $59.1 million under a Rule 10b5-1 trading plan.

πŸ’΅ The company declared a quarterly dividend of $1.56 per share with an annualized yield of 2.2%.

πŸ“ˆ Cigna Group set FY 2026 EPS guidance between 30.350 and 30.39, slightly above analyst predictions.

πŸ₯ Cigna operates a global portfolio including medical plans, dental coverage, and pharmacy benefit management.

πŸ“‰ The stock opened at $289.89 with a 1-year low of $239.51 and a high of $315.47.

πŸ” Institutional ownership stands at 86.99% across various hedge funds and wealth management firms.

Bullish Signals
  • Cigna Group reported Q1 EPS of $7.79, beating analyst consensus estimates of $7.60 by $0.19.
  • Revenue reached $68.52 billion in the quarter, surpassing the consensus estimate of $66.29 billion.
  • Mizuho Securities raised its price objective from $330.00 to $340.00 and reaffirmed an outperform rating.
  • Morgan Stanley increased its price target from $355.00 to $361.00 with an overweight rating.
  • The company achieved a net margin of 2.26% and a return on equity of 19.75% in the reported quarter.
  • Cigna Group declared a quarterly dividend of $1.56 per share, offering a 2.2% annualized yield to shareholders.
  • Revenue grew by 4.6% year-over-year compared to the previous period.
Risk Factors
  • CEO David Cordani sold 201,878 shares for approximately $59.1 million, representing an 85.46% decrease in his ownership position.
  • CAO Jamie G. Kates sold 899 shares for $268,450.39, reducing her personal stake by 27.52%.
Full Analysis
Ascentis Independent Advisors purchased a new stake in Cigna Group (NYSE:CI) totaling 1,964 shares valued at approximately $524,000 during the first quarter. Several other institutional investors also adjusted their positions in the fourth quarter, with Cary Street Partners increasing its stake by 11.0% to own 363 shares worth $100,000, and OLD National Bancorp growing its holdings by 3.7% to reach 1,031 shares valued at $284,000. Analyst sentiment remains positive with Mizuho raising its price objective from $330.00 to $340.00 and Morgan Stanley increasing its target from $355.00 to $361.00. The consensus price target stands at $338.80 based on a Moderate Buy rating, supported by recent earnings where Cigna reported $7.79 EPS, beating the consensus of $7.60, and revenue of $68.52 billion which exceeded estimates. Cigna Group recently declared a quarterly dividend of $1.56 per share paid on June 18th to stockholders of record on June 4th, representing an annualized yield of 2.2%. Despite insider sales by CAO Jamie G. Kates and CEO David Cordani under pre-arranged trading plans, the company maintains a market cap of $76.68 billion with a debt-to-equity ratio of 0.69 and has set FY 2026 guidance for EPS between 30.350 and 30.39.